Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

(2018) Laurel H. Messer et al.   DIABETES CARE

Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch

(2018) Michael P. Stone et al.   Diabetes Technology & Therapeutics

Performance of Medtronic Hybrid Closed-Loop Iterations, Results from a Randomized Trial in Adolescents with Type 1 Diabetes

(2018) Martin de Bock et al.   Diabetes Technology & Therapeutics

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

(2018) Gregory P. Forlenza et al.   Diabetes Technology & Therapeutics

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

(2015) Kellee M. Miller et al.   DIABETES CARE

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

(2014) D. M. Nathan et al.   DIABETES

Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes

(2013) Nalinee Poolsup et al.   Diabetology & Metabolic Syndrome